Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Resource Type
Article
Authors
El-Khoueiry, Anthony B ; Sangro, Bruno ; Yau, Thomas ; Crocenzi, Todd S ; Kudo, Masatoshi ; Hsu, Chiun ; Kim, Tae-You ; Choo, Su-Pin ; Trojan, Jörg ; Welling, Theodore H, 3rd ; Meyer, Tim ; Kang, Yoon-Koo ; Yeo, Winnie ; Chopra, Akhil ; Anderson, Jeffrey ; dela Cruz, Christine ; Lang, Lixin ; Neely, Jaclyn ; Tang, Hao ; Dastani, Homa B ; Melero, Ignacio
Source
In The Lancet 24-30 June 2017 389(10088):2492-2502
Subject
Primary Research Articles
Language
ISSN
0140-6736